Physiomics
PYC · AIM · Health Care · mcap £2.3m · 0.5p
| Date | Type | Announcement | Day |
|---|---|---|---|
| 10 Sep 26 | Physiomics Awarded New Contract Wins
Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce that it has s |
−4.3% | |
| 26 Aug 26 | Holding | Holding(s) in Company | |
| 21 Aug 26 | Holding | Holding(s) in Company | |
| 14 Jul 26 | Director dealing | Director/PDMR Shareholding | |
| 13 Jul 26 | Director dealing | Director/PDMR Shareholding | |
| 08 Jul 26 | Physiomics Awarded Multiple New Contracts
Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce that it has s |
+0.0% | |
| 01 Jul 26 | Board change | Appointment of Chief Operating Officer
Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce the promotion |
+0.0% |
| 30 Jun 26 | Proposed Issue of Equity and Grant of Options
Proposed Issue of Equity and Grant of Options |
−5.0% | |
| 26 Jun 26 | Operations Update
Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, is pleased is pleased to provide sha |
+0.0% | |
| 28 May 26 | Hantavirus Translational Modelling Capability
Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, is pleased to highlight the developm |
−3.6% | |
| 27 May 26 | Physiomics Awarded Multiple Contract Awards
Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce that so far t |
+7.7% | |
| 26 May 26 | Holding | Holding(s) in Company | |
| 21 May 26 | Holding | Holding(s) in Company | |
| 15 May 26 | Board change | Update regarding CEO - Peter Sargent
Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce that Peter Sa |
−2.5% |
| 12 May 26 | Appointment of Stewart Williams as Consultant
Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce the appointme |
−5.5% | |
| 08 May 26 | Strategy Update
Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce that the newl |
+10.0% | |
| 29 Apr 26 | Replacement Result of Meeting and Board Changes
The following amendment has been made to the 'Results of General Meeting and Board Changes' announcement released on 29 April 2026 at 11:00 under RNS No 4220C. |
+10.0% | |
| 29 Apr 26 | Results of General Meeting and Board Changes
Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, announces that all resolutions ("Res |
+10.0% | |
| 24 Apr 26 | Reminder to Vote Against Resolutions
Reminder to Vote Against Resolutions Proposed at Requisitioned General Meeting |
+5.3% | |
| 22 Apr 26 | Launch of Website for Requisitioned Meeting
Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, announces the launch of a dedicated |
+0.0% | |
| 17 Apr 26 | ISS Voting Recommendation
Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, notes the publication of the voting |
−3.0% | |
| 14 Apr 26 | Physiomics Awarded New Contract by Numab
Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce a new contrac |
+0.0% | |
| 08 Apr 26 | Requestioned GM and Investor Presentation
Further to the Company's announcement of 2 April 2026, which contained the Resolutions to be voted on at the requestioned general meeting of the Company (the "Requisitioned General Meeting") to be held at 10.00 a.m. on W |
+0.0% | |
| 02 Apr 26 | Circular & Notice of Requisitioned GM
Publication of Circular and Notice of Requisitioned General Meeting |
+0.0% | |
| 24 Mar 26 | Holding | Holding(s) in Company | |
| 23 Mar 26 | Holding | Holding(s) in Company | |
| 20 Mar 26 | Holding | Holding(s) in Company | |
| 20 Mar 26 | Cancellation of General Meeting
Unless otherwise defined herein, the capitalised terms used in this announcement have the same meaning as those used in the Company's announcements released on 10 March 2026. |
+3.6% | |
| 18 Mar 26 | Fundraise | Result of WRAP Retail Offer
Unless otherwise defined herein, the capitalised terms used in this announcement have the same meaning as those used in the Company's announcements released on 17 March 2026. |
+0.0% |
| 17 Mar 26 | Offer | WRAP Retail Offer for up to £110,000.00
Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions is pleased to announce a revised reta |
−8.6% |
| 17 Mar 26 | Fundraise | Completion of Placing and WRAP Retail Offer Launch
Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce that it has c |
−8.6% |
| 16 Mar 26 | General Meeting Request
The directors of Physiomics plc (AIM: PYC) announce that at 2114h on 13 March 2026 they received a request submitted pursuant to section 303 of the Companies Act 2006 (the "Act") requiring the Board to convene a general |
−7.0% | |
| 13 Mar 26 | Fundraise | Result of WRAP Retail Offer
Unless otherwise defined herein, the capitalised terms used in this announcement have the same meaning as those used in the Company's announcements released on 10 March 2026. |
−4.8% |
| 11 Mar 26 | Holding | Holding(s) in Company | |
| 11 Mar 26 | Holding | Holding(s) in Company | |
| 10 Mar 26 | Offer | WRAP Retail Offer for up to £49,999.98
Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions is pleased to announce a retail offer |
−11.1% |
| 10 Mar 26 | Fundraise | Completion of Placing, Retail Offer & Notice of GM
The Placing Price represents a discount of approximately 33.33 per cent. to the mid-market closing price of an existing ordinary share on 9 March 2026 (being the latest practicable date prior to this announcement). |
−11.1% |
| 16 Feb 26 | Results | Half-year Results
for the six-month period ended 31 December 2025 |
−15.4% |
| 13 Feb 26 | Holding | Holding(s) in Company | |
| 12 Feb 26 | Physiomics Awarded New Contract
Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce a contract aw |
+0.0% | |
| 02 Feb 26 | Holding | Holding(s) in Company | |
| 28 Jan 26 | Physiomics Awarded New Contract by Numab
Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce a new contrac |
+1.8% | |
| 23 Dec 25 | Options Award
Physiomics plc (AIM: PYC), announces an award of share options (the "Options") over ordinary shares of 0.4 pence each in the capital of the Company ("Ordinary Shares"). |
+0.0% | |
| 15 Dec 25 | Physiomics Awarded Follow On Contract by UK Client
Physiomics Awarded Follow On Contract by UK Client |
+7.5% | |
| 11 Dec 25 | Physiomics Awarded New Contract by Numab
Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce a new contrac |
+0.0% | |
| 10 Dec 25 | Physiomics Awarded New Contract by GARDP
Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce a new contrac |
+0.0% | |
| 08 Dec 25 | Holding | Holding(s) in Company | |
| 04 Dec 25 | Physiomics Awarded Two New Contracts
Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce the award of |
+0.0% | |
| 03 Dec 25 | Board change | Directorate Change
Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biometrics company supporting the development of new therapeutics and personalised medicine solutions, announces that Peter Sargent will be st |
−22.7% |
| 18 Nov 25 | Routine | Result of AGM | |
| 17 Oct 25 | Routine | Notice of AGM |
Company filings. Not investment advice.